Marius Pearson

The International Committee of Medical Journal Editors (ICMJE) is consulting on a proposal that authors reporting clinical trials in member journals will be required to share the underlying de-identified individual-patient data with others (Taichman et al., 2016). We believe that this proposal pays insufficient attention to the unique needs of the patients who take part […]

Privilege (/ˈprɪvəlɪdʒ/) ‘A special right, advantage or immunity granted or available only to a particular person or group.’ We all know what privilege is, but it can be difficult to appreciate fully how privilege – or the lack thereof – can affect us. It is especially difficult to understand the challenges faced by people with […]

Oxford PharmaGenesis expertise in rare diseases was showcased in the April edition of PharmaTimes. The article ‘Time To Think Rare’ quoted Commercial Director Dr Richard White (http://tinyurl.com/hhk3xme) alongside other well-known figures in the rare diseases arena, including Alastair Kent (Director of the Genetic Alliance and Chair of Rare Disease UK) and Kay Parkinson (Chief Executive […]

Oxford PharmaGenesis employees past and present were at the centre of the 2nd Annual HEOR Writing Workshop, held in Philadelphia on 17‑18 March 2016 and run by HealthEconomics.com and the Global Outcomes Group with sponsorship from the Mayes College of Healthcare Business and Policy. Attended by a mix of industry, agency and freelance medical writers, […]

Dr Richard White, Commercial Director, and Dr Polly Field, Value Demonstration Leader, attended the Westminster Health Forum Keynote Seminar on Next steps for NICE, priorities for the pharmaceutical industry, and Accelerated Access Review. This was held on Thursday 14 January 2016 and Richard contributed the following article to the transcript of proceedings. The agenda for […]

As a leading healthcare communications company, Oxford PharmaGenesis takes its corporate social responsibilities very seriously. So when Tony Stratton, until recently High Sherriff of Oxfordshire, asked if we’d like to join other top Oxfordshire companies to take a stronger, more sustainable approach to working with local charities in the community, we signed up straight away. […]

Yesterday, Oxford PharmaGenesis really went the extra mile to raise money for Sport Relief. Our keen trotters ran a total of 32.5 miles over courses in Tubney, Oxfordshire, Trafalgar Square, London, and Newtown, PA, USA, and raised more than £300.

Multiple aspects of HealthScience – including rare diseases, real-world evidence, and health economics and outcomes research – were major topics for discussion at the 15th Annual Meeting of The International Publication Planning Association (TIPPA) last week, sponsored by Oxford PharmaGenesis. The meeting, held in San Diego on 29 February–1 March 2016, was attended by a […]

Our research demonstrating the value of professional medical writing support has gained remarkable online attention since publication last week in BMJ Open. Based on a combination of online attention and sharing on social media, our article has achieved an Altmetric score of 52, putting it in the top 5% of all research outputs scored by […]

Oxford PharmaGenesis this week expanded its real-world evidence experience into the areas of respiratory and infectious diseases, with the commissioning of two new SURE™ (Systematic Understanding of Real-World Evidence) assessments. This brings to double digits the number of SURE™ projects initiated in the past 12 months, which have covered cardiology, neurology, diabetes, endocrinology, oncology, immunology […]